• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

EUPATI Launches Educational Toolbox on Medicines Research & Development

Article

EUPATI Launches Educational Toolbox on Medicines Research & Development

Open up and explore the European Patients’ Academy’s (EUPATI’s) new online Toolbox on Medicines Research & Development, available to European patient groups, patient advocates, and anyone who is interested in learning more about the medicines R&D process. “Our vision is that thousands of patient advocates in Europe will leverage the toolbox to enable more meaningful patient involvement and partnership in medicines R&D,” says EUPATI Director Jan Geissler.

Read more here.

Related Videos
Related Content
Howard Berman Discusses Potential Indications for Coya 302

Howard Berman Discusses Potential Indications for Coya 302

April 25th 2024
Article

In an interview with Pharm Exec Associate Editor Don Tracy, Howard Berman, Chairman, CEO, Coya Therapeutics, provides a look into the potential of further indications for Coya 302 amid promising ALS study.

Fierce Females in the Life Science Space

Fierce Females in the Life Science Space

March 29th 2024
Podcast

In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.

Pharma Pulse 4/25/24: Meta’s AI Assistant Can’t Be Trusted, Remote Patient Monitoring Analysis Report 2024 & more

Pharma Pulse 4/25/24: Meta’s AI Assistant Can’t Be Trusted, Remote Patient Monitoring Analysis Report 2024 & more

April 25th 2024
Article

The latest news for pharma industry insiders.

Gen-Z Influence on Pharma M&A

Gen-Z Influence on Pharma M&A

March 14th 2024
Podcast

Ian Baer, Founder and Chief Soothsayer, Sooth, discusses how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract Gen-Z.

Shortell and Durante

Hey Pharma–Do You Know What Your Customers Really Want?

April 24th 2024
Article
Image credit: peterschreiber.media | stock.adobe.com

FDA Grants Accelerated Approval to Day One’s Ojemda for Relapsed or Refractory Pediatric Low-Grade Glioma

April 24th 2024
Article

Ojemda is the first systemic therapy approved by the FDA for the treatment of relapsed or refractory pediatric low-grade glioma harboring a BRAF fusion or rearrangement, or a BRAF V600 mutation.